Assignee
REPLIMUNE LTD
GB·13 granted patents·3 pending applications·81 citations·filing 2017–2025
Top patents by PatentIndex Score
16 records- 0199US11473063B2Oncolytic virus strainREPLIMUNE LTD·Filed 2020·Granted Oct 18, 2022·11 cites·41 claims
- 0299US11427810B2Modified oncolytic virusREPLIMUNE LTD·Filed 2020·Granted Aug 30, 2022·11 cites·24 claims
- 0398US12024724B2Oncolytic virus strainREPLIMUNE LTD·Filed 2022·Granted Jul 2, 2024·3 cites·30 claims
- 0498US10612005B2Modified oncolytic virusREPLIMUNE LTD·Filed 2017·Granted Apr 7, 2020·14 cites·31 claims
- 0597US10947513B2Engineered virusREPLIMUNE LTD·Filed 2017·Granted Mar 16, 2021·11 cites·26 claims
- 0697US10626377B2Use of an oncolytic virus for the treatment of cancerREPLIMUNE LTD·Filed 2017·Granted Apr 21, 2020·11 cites·29 claims
- 0796US10570377B2Oncolytic virus strainREPLIMUNE LTD·Filed 2017·Granted Feb 25, 2020·15 cites·22 claims
- 0895US12397053B2Engineered virusREPLIMUNE LTD·Filed 2023·Granted Aug 26, 2025·1 cites·30 claims
- 0995US12049647B2Engineered virusREPLIMUNE LTD·Filed 2021·Granted Jul 30, 2024·2 cites·40 claims
- 1092US12564633B2Oncolytic virus strainREPLIMUNE LTD·Filed 2024·Granted Mar 3, 2026·0 cites·9 claims
- 1192US2025352646A1Engineered virusREPLIMUNE LTD·Filed 2025·Application pending·0 cites
- 1290US12465639B2Modified oncolytic virusREPLIMUNE LTD·Filed 2023·Granted Nov 11, 2025·0 cites·26 claims
- 1386US12458696B2Modified oncolytic virusREPLIMUNE LTD·Filed 2022·Granted Nov 4, 2025·0 cites·32 claims
- 1486US12059444B2Altered virusREPLIMUNE LTD·Filed 2018·Granted Aug 13, 2024·2 cites·37 claims
- 1579US2024358781A1Altered virusREPLIMUNE LTD·Filed 2024·Application pending·0 cites
- 1646US2021252135A1Treatment using oncolytic virusREPLIMUNE LTD·Filed 2019·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →